Matches in Wikidata for { <http://www.wikidata.org/entity/Q66067343> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66067343 description "clinical trial" @default.
- Q66067343 description "ensayu clínicu" @default.
- Q66067343 description "klinisch onderzoek" @default.
- Q66067343 description "клінічне випробування" @default.
- Q66067343 name "Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial" @default.
- Q66067343 name "Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial" @default.
- Q66067343 type Item @default.
- Q66067343 label "Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial" @default.
- Q66067343 label "Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial" @default.
- Q66067343 prefLabel "Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial" @default.
- Q66067343 prefLabel "Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial" @default.
- Q66067343 P1050 Q66067343-4FC97CA4-44D7-4AA1-8B8F-257E613A3F76 @default.
- Q66067343 P1050 Q66067343-DC1A8FA9-91CD-46D3-91C4-6E1073EBF7ED @default.
- Q66067343 P1132 Q66067343-0007C71F-D1A1-4B1A-9FAD-66E9D71BD4DC @default.
- Q66067343 P1476 Q66067343-6F19964F-B546-4D12-A8D7-86345E49B492 @default.
- Q66067343 P2899 Q66067343-B9C77032-644D-4396-96AC-FE5CBBC2BB8F @default.
- Q66067343 P3098 Q66067343-B4F64D2D-36DC-4A81-93CB-50D3137D6756 @default.
- Q66067343 P31 Q66067343-C0D1260A-8D88-46BB-898B-7627C008410E @default.
- Q66067343 P4844 Q66067343-B25716FE-F33E-4D9C-9275-4DD426729ADE @default.
- Q66067343 P4844 Q66067343-E61723F3-2AED-4A3B-AF59-6DB98BC47C93 @default.
- Q66067343 P580 Q66067343-93972F67-78A5-4AE3-8E74-B073D36830DA @default.
- Q66067343 P582 Q66067343-3026FFC1-95A4-4EEA-8EB0-56D3D8E492E7 @default.
- Q66067343 P6099 Q66067343-120FA6E3-A260-4AC8-BD93-EA8751B41A89 @default.
- Q66067343 P8363 Q66067343-7991B237-56FD-4639-955A-4B647DB0CF52 @default.
- Q66067343 P1050 Q467635 @default.
- Q66067343 P1050 Q58833980 @default.
- Q66067343 P1132 "+510" @default.
- Q66067343 P1476 "Optimizing Prolonged Treatment in Myeloma Using MRD Assessment (OPTIMUM)" @default.
- Q66067343 P2899 "+18" @default.
- Q66067343 P3098 "NCT03941860" @default.
- Q66067343 P31 Q30612 @default.
- Q66067343 P4844 Q20948663 @default.
- Q66067343 P4844 Q425681 @default.
- Q66067343 P580 "2019-08-05T00:00:00Z" @default.
- Q66067343 P582 "2022-06-30T00:00:00Z" @default.
- Q66067343 P6099 Q42824827 @default.
- Q66067343 P8363 Q78089383 @default.